Molecular Dynamics Simulation of Leishmania major
Surface Metalloprotease GP63 (Leishmanolysin)
Gianluca Bianchini,
1
Alessio Bocedi,
1,2
Paolo Ascenzi,
2,3
Enrico Gavuzzo,
4
Fernando Mazza,
1,
*
and
Massimiliano Aschi
1,
*
1
Dipartimento di Chimica, Ingegneria Chimica e Materiali, Universita ´ L’Aquila,L’Aquila, Italy
2
Istituto Nazionale per le Malattie Infettive I.R.C.C.S. Lazzaro Spallanzani, Roma, Italy
3
Dipartimento di Biologia e Laboratorio Interdipartimentale di Microscopia Elettronica, Universita ´ Roma Tre, Roma, Italy
4
Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Roma, Italy
ABSTRACT One of the molecular factors con-
tributing to Leishmania sp. virulence and pathogen-
esis is the major surface metalloprotease GP63,
alternatively called leishmanolysin, MSP, and PSP
(EC 3.4.24.36). Here, the molecular dynamics simula-
tion of Leishmania major GP63 in water at pH 7 is
reported. Upon solvation, GP63 undergoes a sharp
structural relaxation with respect to the crystal
structure. The fluctuation pattern occurs essen-
tially in solvent-exposed nonstructured regions. By
contrast, the active site turns out to be rigid. Essen-
tial dynamics and dynamic-domain analyses, both
carried out on the equilibrated portion of GP63,
show that the fingerprint fluctuations of GP63 are
practically characterized by the motion of a large
part of the N-terminal domain. These results appear
to be in line with substrate recognition and (pro)en-
zyme activation played by the N-terminal domain of
GP63. A systematic analysis among a series of 10
homologs of GP63 also shows that the residues
involved in the interdomain bending result highly
conserved. This finding also suggests possible rela-
tionship between the maintainance of proteolytic
activity and the similarity of the dynamical proper-
ties of the related enzymes. Proteins 2006;64:385–390.
© 2006 Wiley-Liss, Inc.
Key words: Leishmania major; metalloprotease; mo-
lecular dynamics; essential dynamics;
dynamic domain
INTRODUCTION
Leishmania are parasitic trypanosomatids which cause
a broad spectrum of diseases, affecting about 12 millions of
people in tropical and temperate zones of both the Old and
New Worlds. Leishmaniasis can be fatal (visceral form),
grossly disfiguring (mucocutaneous form), or relatively
mild, being localized and in some cases even self-healing
(some forms of cutaneous leishmaniasis).
1–3
Aspartic-, cysteine-, serine-, and metalloproteases ap-
pear to be relevant to several aspects of the Leishmania sp.
life cycle and to affect parasite– host relationships. Among
others, Leishmania sp. proteases play a key role in the
penetration of the parasite into host cells, participate in
the nutrition of the parasite at the expense of the host, and
are involved in the escape mechanisms of the parasite
from the host’s immune system. Therefore, proteases are
regarded as promising targets in the therapeutic treat-
ment of leishmaniasis. In fact, protease inhibitors block
Leishmania sp. replication and differentiation, providing
an alternative to traditional therapy against drug-
resistant parasites. Furthermore, Leishmania sp. pro-
teases are attractive vaccine candidates.
4 –12
GP63, alternatively called leishmanolysin, MSP, and
PSP (EC 3.4.24.36), is a metalloprotease belonging to the
metzincin class, representing the major surface protease of
Leishmania sp. GP63 contributes to parasite virulence and
pathogenesis, participating in resistance of promastigotes
to complement-mediated lysis and in receptor-mediated
uptake of leishmania. In addition to the surface-associated
enzyme, recent evidence suggests that active GP63 is
released from promastigotes by autoproteolysis of GPI-
linked GP63 and/or secretion of intracellular GP63. Inter-
estingly, GP63 is a drug target and vaccine candi-
date.
7,13,14
GP63 is expressed on both promastigotes and amasti-
gotes of all Leishmania sp. and has a wide substrate
specificity and pH optimum, in particular GP63 from L.
major is optimally active at neutral to alkaline pH. GP63
degrades many protein substrates including casein, azoca-
sein, gelatin, albumin, hemoglobin, fibrinogen, and CD4
molecules on human T cells.
7
GP63 (478 amino acid residues) contains predominantly
-sheet secondary structure and consists of the N-
terminal, the central, and the C-terminal domains. The
N-terminal domain contains the His264 and His268 cata-
lytic residues within the HisGluXxxXxxHis signature.
Abbreviations: DynDom, dynamic domain; ED, essential dynamics;
GP63, Leishmania major surface metalloprotease (also named leish-
manolysin or MSP or PSP); MD, molecular dynamics; MMP-8, human
neutrophyl collagenase; RMSD, root-mean-square deviation; RMSF,
root-mean-square fluctuation.
Grant sponsor: Ministero dell’Istruzione, dell’Universita ´ e della
Ricerca of Italy; Grant number: PRIN-COFIN-2003.
*Correspondence to: Massimiliano Aschi, Fernando Mazza Diparti-
mento di Chimica, Ingegneria Chimica e Materiali, Universita ´ L’Aquila,
Via Vetoio, Coppito, 67100 L’Aquila, Italy. E-mail: aschi@caspur.it or
mazza@univaq.it
Received 24 September 2005; Accepted 3 November 2005
Published online 17 May 2006 in Wiley InterScience
(www.interscience.wiley.com). DOI: 10.1002/prot.21009
PROTEINS: Structure, Function, and Bioinformatics 64:385–390 (2006)
© 2006 WILEY-LISS, INC.